Presbyopia Drops, a Promising Solution - Takeaways - MDSpire

Presbyopia Drops, a Promising Solution

  • By

  • Irene Zhou, BS, MS3

  • Ariana Rose Maleki, BS

  • Dagny Zhu, MD

  • April 1, 2025

  • 9 min

Share

  • 1

    Presbyopia drops, such as Vuity and Qlosi, offer a non-invasive alternative for managing near vision in patients over 40.

  • 2

    Clinical trials demonstrated that presbyopia drops significantly improve near vision while preserving distance vision, even in low-light conditions.

  • 3

    Careful patient selection and education are crucial for optimal outcomes, particularly for motivated individuals aged 40 to 50 with early to moderate presbyopia.

  • 4

    The FDA approved a twice-daily dosing option for Vuity in 2023, extending its effectiveness from 6 to 9 hours.

  • 5

    Common side effects of presbyopia drops include headaches and eye irritation, emphasizing the importance of patient counseling and adherence.

Original Source(s)

Related Content